Navigation Links
Gene mutations in mice mimic human-like sleep disorder, UT Southwestern researchers find
Date:5/20/2008

DALLAS May 20, 2008 Mutations in two genes that control electrical excitability in a portion of the brain involved in sleep create a human-like insomnia disorder in mice, UT Southwestern Medical Center researchers have found. The findings may help scientists better understand the disorder and provide an animal model for developing treatments.

This is one of the most dramatic sleep-disturbance mutations, said Dr. Rolf Joho, associate professor of neuroscience and senior author of the paper, which appears online today and in the May 21 issue of The Journal of Neuroscience. The mice sleep half as much as normal mice.

The mutant mice appeared to have a condition similar to a human disorder called sleep maintenance insomnia, in which sufferers can get to sleep, but dont remain at rest for long.

Were trying to look at where in the brain this originates, Dr. Joho said. The same mechanism could be involved in many neurophysiological disorders.

The researchers focused on two genes that encode molecules known as ion channels. An ion channel is a pore that spans a cells membrane, opening and closing to allow charged atoms, or ions, to cross the membrane. The coordinated opening and closing of various ion channels allows nerve cells to carry electrical signals.

In the current study, the researchers examined two channels that allow potassium ions to cross the cell membrane. The researchers genetically engineered mice to have defects in the ion channels Kv3.1 and Kv3.3, which normally open and close much faster than other potassium channels.

These channels are common in a portion of the brain called the thalamic reticular nucleus, which is thought to act as a pacemaker during sleep, controlling slow-wave sleep the deep, restful sleep that occurs without dreams.

The mutant mice slept only 50 percent to 60 percent as much as normal mice. Measurements of their brain waves showed that they entered slow-wave sleep, but only for short periods before waking again.

The mice did not readily get restful sleep even after sleep deprivation, the researchers found.

In future studies, the researchers hope to focus on the Kv3.1 mutation alone, which they believe, based on previous studies might be the primary factor in the sleep disturbances, while Kv3.3 mutations might affect muscle coordination.

The researchers also plan to investigate ways to restore function of Kv3.1 with potential drugs. So far, there are no medications that affect this ion channel.


'/>"/>

Contact: Aline McKenzie
aline.mckenzie@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related biology news :

1. Rare genetic mutations protect against hypertension
2. CSHL scientists part of team that discovers role of rare gene mutations in schizophrenia
3. Should children be permitted to get genetic testing for BRCA 1/2 mutations?
4. New study reveals for first time how BRCA1 mutations cause breast cancer
5. Genetic variant mimics effect of heart failure medications
6. Researchers mimic bacteria to produce magnetic nanoparticles
7. Zoologists challenge longstanding theory that eyespots mimic the eyes of predators enemies
8. Team of chemists receives $5 million grant to develop enzyme mimics
9. 4 days of REM sleep deprivation contributes to a reduction of cell proliferation in rats
10. Snoozing worms help Penn researchers explain the evolution of sleep
11. Journal Sleep: Insomniacs are more likely to report a family history of the sleep disorder
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene mutations in mice mimic human-like sleep disorder, UT Southwestern researchers find
(Date:11/29/2016)... , November 29, 2016 Nearly one billion ... Continue Reading ... ... part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The ...
(Date:11/22/2016)... Nov. 22, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Healthcare and Life Sciences Awards as "Most Outstanding ... an unprecedented year of recognition and growth for MedNet, ... 15 years. iMedNet ™ , ...
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. ... billion KRW (US $18.9M) Series A financing. This financing ... G.N. Tech Venture and SNU Bio Angel. This new ... 30.5 billion KRW (US $27.7M) since its founding in ... to bolster the development and commercialization of its immuno-oncology ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... I/II dose escalation and expansion clinical trial for its lead drug candidate, AC0010, ... purpose of the trial was to determine the safety, antitumor activity, and recommended ...
(Date:12/7/2016)... , Dec. 7, 2016 Neogen Corporation (NASDAQ: ... Dr. Dan Kephart as its chief science ... will assume his responsibilities at Neogen effective Jan. 1. ... director for the agribusiness unit of Thermo Fisher Scientific, ... at Life Technologies. His extensive industry experience also includes ...
Breaking Biology Technology: